ARTELO BIOSCIENCES, INC.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-2.4M | $-3.0M | $-3.1M | $-3.2M | $-2.4M | $-1.1M | $-2.4M | $-2.5M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | — | $401.0K | $432.0K | $150.0K | $192.0K | $209.0K | $195.0K | $213.0K |
| Net Cash from Operating Activities | $-5.0M | $-1.2M | $-3.5M | $-514.0K | $-1.6M | $-778.0K | $-2.1M | $-2.9M |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | — | — | — | $0 | — | — | $1.3M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | — | $10.9M | — | — | $0 | — | — | $55.0K |
| Net Change in Cash | — | $9.7M | — | — | $-1.6M | — | — | $-1.6M |
| Free Cash Flow | — | — | — | — | — | — | — | — |